Understand the source comparison
Best Research Peptides for ADHD Research: Mechanism Comparison
Semax Increases dopamine/norepinephrine turnover via BDNF-mediated tyrosine hydroxylase upregulation Intranasal 0.1–0.3% solution, 2–3 drops per nostril twice daily 7–14 days for measurable attentional improvements Best-suited for primary attention and impulse
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Semax
- Increases dopamine/norepinephrine turnover via BDNF-mediated tyrosine hydroxylase upregulation
- Intranasal
- 0.1–0.3% solution, 2–3 drops per nostril twice daily
- 7–14 days for measurable attentional improvements
- Best-suited for primary attention and impulse control deficits. Addresses catecholamine dysregulation without stimulant side effects
- Selank
- Upregulates GABA-A receptor density; modulates serotonin metabolism
- 0.15% solution, 2–3 drops per nostril twice daily
- 5–10 days for anxiety reduction; 10–14 days for attentional effects
- Ideal for ADHD with comorbid anxiety. Enhances inhibitory control and reduces anxiety-driven distractibility
- Cerebrolysin
- Mimics neurotrophic factor activity (NGF, BDNF, CNTF); promotes dendritic growth
- Intramuscular injection
- 5–30ml per session, 3×/week for 4–6 weeks
- 3–4 weeks for structural changes; cognitive effects emerge gradually
- Targets structural neuroplasticity. Best for long-term intervention addressing grey matter deficits, not acute symptom management
- P-21 (Pinealon)
- Enhances norepinephrine synthesis in locus coeruleus
- Subcutaneous injection
- 100–200mcg daily
- 7–10 days
- Selective for arousal and working memory systems. Particularly effective in high-impulsivity phenotypes
- Dihexa
- Potentiates hepatocyte growth factor signaling; enhances synaptic plasticity
- Oral (in research models)
- 0.5–2mg/kg in preclinical studies
- 2–3 weeks for cognitive enhancement
- Promising for learning and memory deficits. Not yet tested in ADHD-specific populations